CRA International delivered a clean second-quarter fiscal 2026 print, with the consulting franchise demonstrating strong momentum across both core practice lines and international markets. Revenue growth ran ahead of the prior-year period on a stable utilization rate near the high seventies. Consultant headcount stood at 968. Diluted EPS reached $2.10, against $1.79 in the prior-year quarter, on broad-based demand across the litigation, regulatory, and management consulting practice lines. The reported international margin outcome looks stable despite the staffing ramp underway across global offices. Fixed-price project mix rose sharply in the prior-year quarter. Year-to-date revenue landed at $411.8M against $368.7M a year earlier. Year-to-date diluted EPS of $3.79 compared against $4.42 in the prior-year period. The overall demand environment has held up well across the consulting practice lines despite macro uncertainty in the broader business services market, and management commentary points to continued operating discipline in the back half of the fiscal year.
Operating margin compressed on accelerated forgivable loan amortization and higher compensation expense, a margin pattern that mirrors prior cycles of expert-staff investment. The same dynamic historically resolves over multiple quarters as new consultants ramp toward firm-average productivity. The balance sheet reset reflects a deliberate pivot toward flexibility, with cash of $21.4M and revolver outstanding of $219M. A subsequent $75M term loan was signed at the close of July, locking in capacity through July 2031. Capital return continues at a measured cadence, with $49.3M of YTD buybacks against a quarterly dividend of $0.57 per share, reflecting active use of the credit facility as a working-capital bridge rather than a permanent funding layer. The board's measured approach to capital return is consistent with the firm's positioning as a knowledge-services franchise with modest cyclicality rather than a leveraged buyback vehicle. The board continues to prioritize strategic flexibility over near-term capital deployment intensity, with each quarter's allocation decisions informed by the post-ramp margin trajectory and the relative attractiveness of organic investment versus opportunistic tuck-in acquisitions.
Valuation at $172.6 sits within a fifty-two week trading band. The fifty-two-week low sits at $132.17, while the recent peak reached $227.29. The current price translates to a forward P/E near 18x on consensus FY2027 expectations, positioning the equity near the high end of its historical trading band. The premium valuation reflects the firm's track record of margin recovery following expert-staff ramp periods, plus the asset-light consulting model that produces low capex intensity. The case for incremental ownership rests on three structural attributes: expert-staff leverage, balance sheet capacity for opportunistic M&A, and recurring demand for independent expert testimony across complex disputes. Execution risk centers on bonus accrual volatility and project mix sensitivity, with the marginal investor likely to underweight the equity until margin recovery is clearly demonstrated in subsequent filings. The investment case is therefore neither a contrarian deep-value opportunity nor a momentum growth play, but rather a quality-franchise re-rating thesis tied to demonstrated margin recovery over the next several quarters.